Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 46 clinical trials
Endoscopic Sinus Surgery in Recurrent Acute Rhinosinusitis

The aim of this study is to find out if endoscopic sinus surgery improves the quality of life in patients suffering from recurrent acute rhinosinusitis. Our main outcome is the difference between the average change in disease-specific SNOT-22 quality of life questionnaire scores (from baseline to 5-6 months follow-up) between …

antibiotic
nasal congestion
antibiotic therapy
sinusitis
corticosteroids
  • 0 views
  • 16 Feb, 2024
  • 1 location
Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia

To assess the clinical efficacy of ANG-3777 relative to the standard of care in reducing the severity and progression of pulmonary and renal dysfunction and mortality in adult patients hospitalized with COVID-19 pneumonia

pneumonia
chest imaging
renal impairment
covid-19
SARS
  • 0 views
  • 05 Aug, 2020
A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19)

This is a randomized, double-blind, placebo-controlled, multicenter, 28-day study of adult participants hospitalized with COVID-19, with a safety follow-up telephone call at Day 60.

fever
x-rays
chest x-ray
coronavirus infection
covid-19
  • 0 views
  • 16 Feb, 2024
  • 5 locations
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation

The purpose of this prospective, Phase 2, multicenter, blinded, randomized placebo controlled study is to demonstrate that early treatment with mavrilimumab prevents progression of respiratory failure in patients with severe COVID-19 pneumonia and clinical and biological features of hyper-inflammation.

pneumonia
fever
hypoxia
acute respiratory failure
x-rays
  • 0 views
  • 01 Feb, 2023
  • 1 location
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation

The purpose of this prospective, Phase 2, multicenter, blinded, randomized placebo controlled study is to demonstrate that early treatment with mavrilimumab prevents progression of respiratory failure in patients with severe COVID-19 pneumonia and clinical and biological features of hyper-inflammation.

pneumonia
fever
hypoxia
acute respiratory failure
x-rays
  • 0 views
  • 01 Feb, 2023
  • 2 locations
Multiomics After Cold Pressor Test of People Who Are Unable to Have Headache

The investigators will measure multiomic changes (transcriptomics and metabolomics) after pain induction by Cold Pressor Test. 3 blood samples, two for RNA and one for metabolites are taken 5 minutes before a Cold Pressor Test and again 1 hour after the Cold Pressor Test.

cold
after pain
headache
5 minutes
pressor
  • 0 views
  • 16 Feb, 2024
  • 1 location
Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19

This phase III trial compares low dose whole lung radiation therapy to best supportive care plus physicians choice in treating patients with COVID-19 infection. Low dose whole lung radiation therapy may work better than the current best supportive care and physician's choice in improving patients' clinical status, the radiographic appearance …

pneumonia
fever
covid-19
cough
dyspnea
  • 0 views
  • 16 Feb, 2024
  • 1 location
Manual Trial Test

Manual Trial overview.

  • 0 views
  • 19 Jul, 2023
  • 5 locations
Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia

Vitamin C is significant to human body and plays a role in reducing inflammatory response and preventing common cold. In addtion, a few studies have shown that vitamin C deficiency is related to the increased risk and severity of influenza infections.

pneumonia
antiviral drugs
respiratory infection
coronavirus infection
respiratory tract infection
  • 0 views
  • 16 Feb, 2024
  • 1 location
Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19

Brief Summary: The goal here is to evaluate dipyridamole in treating respiratory tract infection and circulatory dysfunction due to SARS-CoV-2 coronavirus in hospitalized CVID-19 patients. Infection with SARS-CoV-2 causes human COVID-19 (HCoV-19).

vasoconstrictor
fever
intermittent positive pressure ventilation
critically ill
sore throat
  • 0 views
  • 16 Feb, 2024
  • 1 location